IHMA Europe

IHMA is a premier global contract research organization (CRO) specializing in the development of anti-infective products. The company provides extensive microbiology services, including antimicrobial susceptibility testing (AST), molecular characterization of resistance, and large-scale global surveillance programs. IHMA Europe, located in Switzerland, serves as a key hub for supporting clinical trials and research initiatives across the European and international markets. Their expertise spans the entire drug development lifecycle, from early-stage discovery and preclinical evaluation to Phase 4 post-marketing studies. By focusing exclusively on infectious diseases, IHMA offers specialized laboratory services and regulatory guidance to pharmaceutical and diagnostic companies worldwide.